Sandu Pharmaceuticals submits Copy of Limited Review Report

15 Mar 2013 Evaluate

Sandu Pharmaceuticals has submitted a copy of the limited review report for the period ended December 31, 2012.

The above information is a part of company’s filings submitted to BSE.

Sandu Pharmaceutical Share Price

38.74 0.71 (1.87%)
30-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.60
Dr. Reddys Lab 1265.95
Cipla 1491.40
Zydus Lifesciences 901.30
Lupin 2081.00
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×